Biointerfacial phenomena of amlodipine buccomucosal tablets of HPMC matrix system containing polyacrylate polymer/β-cyclodextrin: Correlation of swelling and drug delivery performance

References

• Meredith PA, Elliott HL. Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet. 1992;22:22–31. DOI:10.2165/00003088-199222010-00003.
   PubMed Web of Science ®Google Scholar
• Abernethy DR. Pharmacokinetics and pharmacodynamics of amlodipine. Cardiolog. 1992;80(Suppl1):31–36. DOI:10.1159/000175050.
   PubMed Web of Science ®Google Scholar
• Lopez FL, Ernest TB, Tuleu C, et al. Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms. Expert Opin Drug Deliv. 2015;12: 1727–1740. Published online: 13 Jul 2015 DOI:10.1517/17425247.2015.1060218
   PubMed Web of Science ®Google Scholar
• Jang D-J, Jeong EJ, Lee H-M, et al. Improvement of bioavailability and photostability of amlodipine using redispersible dry emulsion. Eur J Pharm Sci. 2006;28(5):405–11. DOI:10.1016/j.ejps.2006.02.014.
   PubMed Web of Science ®Google Scholar
• Stoiljković ZZ, Jovanović VM, Dž M, et al. The electrochemical investigation of inclusion complexes of nifedipine and amlodipine with β-cyclodextrin and (2-hydroxypropyl)-β-cyclodextrin. Int J Electrochem Sci. 2013;8:9543–9557.
   Web of Science ®Google Scholar
• Mielcarek J. Photochemical stability of the inclusion complexes formed by modified 1,4-dihydropyridine derivatives with β-cyclodextrin. J Pharm Biomed Anal. 1997;15:681–686.
   PubMed Web of Science ®Google Scholar
• Kleinbloesem CH, van Brummelen P, Breimer DD. Nifedipine. relationship between pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 1987;12(1):12–29. DOI:10.2165/00003088-198712010-00002.
   PubMed Web of Science ®Google Scholar
• Harten JV, Danhof M, Burggraaf K, et al. Negligible sublingual absorption of nifedipine. Lancet. 1987;330(8572):1363–1365. DOI:10.1016/S0140-6736(87)91258-X.
   Google Scholar
• Soyka M. Buprenorphine–naloxone buccal soluble film for the treatment of opioid dependence: current update. Expert Opin Drug Deliv. 2015;12:339–347. DOI:10.1517/17425247.2014.953479.
   PubMed Web of Science ®Google Scholar
• Preis M, Woertz C, Kleinebudde P, et al. Oromucosal film preparations: classification and characterization methods. Expert Opin Drug Deliv. 2013;10:1303–1317. DOI:10.1517/17425247.2013.804058.
   PubMed Web of Science ®Google Scholar
• Park J-B, Prodduturi S, Morott J, et al. Development of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology. Expert Opin Drug Deliv. 2015;12:1–13. DOI:10.1517/17425247.2014.949235.
   PubMed Web of Science ®Google Scholar
• Rathbone MJ, Ponchel G, Ghazali FA. Systemic and oral mucosal drug delivery and delivery systems. In: Rathbone MJ, editor. Oral mucosal drug delivery. Vol. 74. New York: Marcel Dekker Inc; 1996. p. 241–284.
   Google Scholar
• Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci. 1992;81:1–10.
   PubMed Web of Science ®Google Scholar
• Hoogstraate AJ, Senel S, Cullander C, et al. Effects of bile salts on transport rates and routes of FTIC-labelled compounds across porcine buccal epithelium in vitro. J Control Release. 1996;40:211–221. DOI:10.1016/0168-3659(95)00187-5.
   Web of Science ®Google Scholar
• Kamei N, Morishita M, Chiba H, et al. Complexation hydrogels for intestinal delivery of interferon β and calcitonin. J Control Release. 2009;134:98–102. DOI:10.1016/j.jconrel.2008.11.026.
   PubMed Web of Science ®Google Scholar
• Nagai T, Machida Y. Buccal delivery systems using hydrogels. Adv Drug Deliv Rev. 1993;11:179–191. DOI:10.1016/0169-409X(93)90032-Y.
   Web of Science ®Google Scholar
• Merkle HP, Wolany GJM. Mucoadhesive patches for buccal peptide administration. In: Duchˆene D, editor. Buccal and nasal administration as an alternative to parenteral administration. Paris: Editions de Sante´; 1996. p. 110–124.
   Google Scholar
• Taylan B, Capan Y, Gu¨ven O, et al. Design and evaluation of sustained-release and buccal adhesive propranolol hydrochloride tablets. J Control Release. 1996;38:11–20. DOI:10.1016/0168-3659(95)00094-1.
   Web of Science ®Google Scholar
• Nokhodchi A, Asare-Addo K. Drug release from matrix tablets: physiological parameters and the effect of food. Expert Opin Drug Deliv. 2014;11:1401–1418. DOI:10.1517/17425247.2014.924498.
   PubMed Web of Science ®Google Scholar
• Mohapatra R, Senapati S, Sahoo C, et al. Transcorneal permeation of diclofenac as a function of temperature from film formulation in presence of triethanolamine and benzalkonium chloride. Colloids Surf B. 2014;123:170–180. DOI:10.1016/j.colsurfb.2014.09.012.
   PubMed Web of Science ®Google Scholar
• Panda B, Parihar AS, Mallick S. Effect of plasticizer on drug crystallinity of hydroxypropyl methylcellulose matrix film. Int J Biol Macromol. 2014;67:295–302. DOI:10.1016/j.ijbiomac.2014.03.033.
   PubMed Web of Science ®Google Scholar
• Hosny EA, Elkheshen SA, Saleh SI. Buccoadhesive tablets for insulin delivery: in-vitro and in-vivo studies. Boll Chim Farm. 2002;141:210–217.
   PubMedGoogle Scholar
• Lee VHL, Yamamoto A, Kompella MB. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit Dev Ther Drug Carrier Syst. 1991;8:91–92.
   PubMed Web of Science ®Google Scholar
• Şenel S, Hıncal AA. Drug permeation enhancement via buccal route: possibilities and limitations. J Control Release. 2001;72:133–144. DOI:10.1016/S0168-3659(01)00269-3.
   PubMed Web of Science ®Google Scholar
• Sridevi S, Divan PVR. Optimized transdermal delivery of ketoprofen using pH and hydroxypropyl-β-cyclodextrin as co-enhancers. Eur J Pharm Biopharm. 2002;54:151–154. DOI:10.1016/S0939-6411(02)00056-5.
   PubMed Web of Science ®Google Scholar
• Pattnaik S, Swain K, Bindhani A, et al. Influence of chemical permeation enhancers on transdermal permeation of alfuzosin: an investigation using response surface modeling. Drug Dev Ind Pharm. 2011;37:465–474. DOI:10.3109/03639045.2010.522192.
   PubMed Web of Science ®Google Scholar
• Mura P, Faucci MT, Parrini PL, et al. Influence of the preparation method on the physicochemical properties of ketoprofen–cyclodextrin binary systems. Int J Pharm. 1993;179:117–128. DOI:10.1016/S0378-5173(98)00390-1.
   Web of Science ®Google Scholar
• Mura P, Bettinetti GP, Manderioli A, et al. Interactions of ketoprofen and ibuprofen with β-cyclodextrin in solution and in the solid state. Int J Pharm. 1998;166:189–203. DOI:10.1016/S0378-5173(98)00035-0.
   Web of Science ®Google Scholar
• Semalty A. Cyclodextrin and phospholipid complexation in solubility and dissolution enhancement: a critical and meta-analysis. Expert Opin Drug Deliv. 2014;8:1255–1272. DOI:10.1517/17425247.2014.916271.
   Web of Science ®Google Scholar
• Chilajwar SV, Pednekar PP, Jadhav KR, et al. Cyclodextrin-based nanosponges: a propitious platform for enhancing drug delivery. Expert Opin Drug Deliv. 2014;11:111–120. DOI:10.1517/17425247.2014.865013.
   PubMed Web of Science ®Google Scholar
• Mallick S, Pattnaik S, Swain K, et al. Current perspectives of solubilization: potential for improved bioavailability. Drug Dev Ind Pharm. 2007;33:865–873. DOI:10.1080/03639040701429333.
   PubMed Web of Science ®Google Scholar
• George S, Vasudevan D. Studies on the preparations, characterization and solubility of 2-HP-β-cyclodextrin-meclizine HCl inclusion complexes. J Young Pharm. 2012;4:220–227. DOI:10.4103/0975-1483.104365.
   PubMedGoogle Scholar
• Mallick S, Mondal A, Sannigrahi S. Kinetic measurements of the hydrolytic degradation of cefixime: effect of Captisol complexation and water-soluble polymers. J Pharm Pharmacol. 2008;60:833–841. DOI:10.1211/jpp/60.10.0006.
   PubMed Web of Science ®Google Scholar
• Parodi B, Russo E, Caviglioli G, et al. Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride. Drug Dev Ind Pharm. 1996;22:445–450. DOI:10.3109/03639049609069353.
   Web of Science ®Google Scholar
• Mallick S, Pradhan SK, Chandran M, et al. Study of particle rearrangement, compression behavior and dissolution properties after melt dispersion of ibuprofen, avicel and aerosil. Result Pharm Sci. 2011;1:1–10. DOI:10.1016/j.rinphs.2011.05.003.
   PubMedGoogle Scholar
• Panda B, Digdarsini T, Mallick S. Physicomechanical and physicochemical characterizations of biexponential compaction process of paracetamol in the presence of talcum-lubricated-MCC. Powder Technol. 2015;273:91–101. DOI:10.1016/j.powtec.2014.12.039.
   Web of Science ®Google Scholar
• Desai KG, Kumar TM Preparation and evaluation of a novel buccal adhesive system. AAPS PharmSciTech. 2004;5(3):Article 35. (http://www.aapspharmscitech.org)
   Google Scholar
• Manganaro AM, Wertz PW. The effects of permeabilizers on the in vitro penetration of propranolol through porcine buccal epithelium. Mil Med. 1996;161:669–672.
   PubMed Web of Science ®Google Scholar
• Patel VM, Prajapati BG, Patel HV, et al. Mucoadhesive bilayer tablets of propranolol hydrochloride. AAPS PharmSciTech. 2007;8(3):Article 77. DOI:10.1208/pt0803077.
   Google Scholar
• Patel VM, Prajapati BG, Patel MM. Design and characterization of chitosan-containing mucoahesive buccal patches of propranolol hydrochloride. Acta Pharm. 2007;57:61–72.
   PubMedGoogle Scholar
• Korsmeyer RW, Guruy R, Doelker E, et al. Mechanism of solute release from porous polymers. Int J Pharm. 1983;15:25–35. DOI:10.1016/0378-5173(83)90064-9.
   Web of Science ®Google Scholar
• Mahnaj T, Ahmed SU, Plakogiannis FM. Characterization of ethyl cellulose polymer. Pharm Dev Technol. 2013;18(5):982–989. DOI:10.3109/10837450.2011.604781.
   PubMed Web of Science ®Google Scholar
• Gohel MC, Parikh RK, Aghara PY, et al. Application of simplex lattice design and desirability function for the formulation development of mouth dissolving film of salbutamol sulphate. Curr Drug Deliv. 2009;6:486–494. DOI:10.2174/156720109789941696.
   PubMedGoogle Scholar
• Muzib YI, Kumari KS. Mucoadhesive buccal films of glibenclamide: Development and evaluation. Int J Pharm Investig. 2011;1:42–47. DOI:10.4103/2230-973X.76728.
   PubMedGoogle Scholar
• De P, Damodharan N, Mallick S, et al. Development and evaluation of nefopam transdermal matrix patch system in human volunteers. PDA J Pharm Sci Technol. 2009;63:537–546.
   PubMedGoogle Scholar
• Mielcarek J, Czernielewska A, Czarczyńska B. Inclusion complexes of felodipine and amlodipine with methyl-β-cyclodextrin. J Incl Phenom Macro. 2006;54:17–21. DOI:10.1007/s10847-005-2603-9.
   Web of Science ®Google Scholar
• Castro-Hermida JA, GóMez-Couso H, Ares-Mazás ME, et al. Anti cryptosporidial activity of furan derivative G1 and its inclusion complex with beta-cyclodextrin. J Pharm Sci. 2004;93:197–206. DOI:10.1002/jps.10528.
   PubMed Web of Science ®Google Scholar
• Bonacucina G, Martelli S, Palmieri GF. Rheological, mucoadhesive and release properties of carbopol gels in hydrophilic cosolvents. Int J Pharm. 2004;282:115–130. DOI:10.1016/j.ijpharm.2004.06.012.
   PubMed Web of Science ®Google Scholar
• Edsman K, Hägerström H. Pharmaceutical applications of mucoadhesion for the non-oral routes. J Pharm Pharmacol. 2005;57:3–22. DOI:10.1111/(ISSN)2042-7158.
   PubMed Web of Science ®Google Scholar
• Ulery BD, Nair LS, Laurencin CT. Biomedical applications of biodegradable polymers. J Polym Sci. 2011;49:832–864. DOI:10.1002/polb.22259.
   Web of Science ®Google Scholar
• Soares JS, Zunino P. A mixture model for water uptake, degradation, erosion and drug release from polydisperse polymeric networks. Biomater. 2010;13:3032–3042. DOI:10.1016/j.biomaterials.2010.01.008.
   Web of Science ®Google Scholar
• Fredenberg S, Wahlgren M, Reslow M, et al. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review. Int J Pharm. 2011;415:34–52. DOI:10.1016/j.ijpharm.2011.05.049.
   PubMed Web of Science ®Google Scholar
• Bravo SA, Lamas MC, Salamón CJ. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices. J Pharm Pharm Sci. 2002;5:213–219.
   PubMed Web of Science ®Google Scholar
• Bravo SA, Lamas MC, Salomon CJ. Swellable matrices for the controlled release of diclofenac sodium: formulation and in vitro studies. Pharm Dev Technol. 2004;9:75–83. DOI:10.1081/PDT-120027420.
   PubMed Web of Science ®Google Scholar
• Sangalli ME, Zema L, Maroni A, et al. Influence of beta-cyclodextrin on the release of poorly soluble drugs from inert and hydrophilic heterogeneous polymeric matrices. Biomater. 2001;22:2647–2651. DOI:10.1016/S0142-9612(01)00005-9.
   PubMed Web of Science ®Google Scholar
• Leticia SK, Clarissa RX, Paulo M, et al. Influence of β-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets. Eur J Pharm Biopharm. 2003;55:85–91. DOI:10.1016/S0939-6411(02)00127-3.
   PubMed Web of Science ®Google Scholar
• Senel S, Capan Y, Sargon MF, et al. Histological bioadhesion studies on buccal and bioadhesive tablets containing a penetration enhancer sodium glycodeoxycholate. Int J Pharm. 1998;170:239–245. DOI:10.1016/S0378-5173(98)00148-3.
   Web of Science ®Google Scholar
• Shojaei AH, Chang RK, Guo X, et al. Systemic drug delivery via the buccal mucosal route. Pharm Technol. 2001;29:70–81.
   Google Scholar
• Pandab A, Behera M, Mohapatra R, et al. Influence of plasticizer on ocular permeation of acetazolamide from film formulations. Proceedings of International Symposium 64th Indian Pharmaceutical Congress; Chennai; 2012;E–178
   Google Scholar
• Pund S, Rasve G, Borade G. Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa. Eur J Pharm Sci. 2013;48:195–201. DOI:10.1016/j.ejps.2012.10.029.
   PubMed Web of Science ®Google Scholar
• Penjuri SCB, Damineni S, Ravouru N. Design and development of buccal mucoadhesive drug delivery system for perindopril. Jordan J Pharm Sci. 2015;8:37–49.
   Google Scholar
• Brahmankar DM, Jaiswal SB. Biopharmaceutics and pharmacokinetics - A treatise. Delhi: Vallabh Prakashan; 2010.
   Google Scholar